Mestinon 10 mg or 60 mg Tablets
PDF Leaflet Revision Date: 29 September 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of myasthenia gravis.
Dosage (summary)
Adults: 1-3 tablets (60 mg) 2-4 times daily; Children: 7 mg/kg daily.
Special Populations
- Renal impairment
- Elderly patients
- Obstructive respiratory diseases
Pregnancy & Breastfeeding
Safety during pregnancy and breastfeeding not established.
Key Drug Interactions
- Corticosteroids may decrease MESTINON requirement
- Antimuscarinics antagonize muscarinic effects
- Aminoglycoside antibiotics may interact
Contraindications
- Hypersensitivity to pyridostigmine or bromides
- Mechanical intestinal or urinary obstruction
Common side effects
- Muscle cramps
- Fasciculation
- Nausea
- Diarrhoea
- Bradycardia
Counselling Points
- Monitor for signs of overdose
- Report any severe side effects
- Take with caution if pregnant or breastfeeding
Serious warnings
- Risk of cholinergic crisis
- Caution in patients with arrhythmias
- Care in renal impairment
Important Disclaimer
The Mestinon 10 mg or 60 mg Tablets professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
